Healthcare professionals discuss the importance of patient characteristics and comorbidities in selecting effective and tolerable treatments.
Tim A. Richardson, MD
Advertisement
Articles by Tim A. Richardson, MD
Healthcare professionals discuss the importance of patient characteristics and comorbidities in selecting effective and tolerable treatments.
Mechanisms of Action and Differentiation Among ARPI Therapies in mCSPC
Current Treatment Landscape and Guideline Recommendations in mCSPC
“Before long, what we do, how we do it, and when we do it might solely be based off of those genetic testing results,” says Tim Richardson, MD.
Tim A. Richardson, MD, outlines the 2 key scenarios for utilizing genetic testing in clinical practice.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants clearance to Hugo robotic-assisted surgery system for urologic procedures
2
Apalutamide is linked to fewer CNS-related conditions in patients with nmCRPC
3
Prostate MRI is linked with higher sensitivity, NPV vs micro-ultrasound in pilot study
4
BOND-003: Cretostimogene yields durable 24-month responses in high-grade NMIBC
5
